Who We Are

The Company
Luciole is a start-up company focusing on the discovery and development of small molecules that accelerate the repair of oxidative damage to mitochondrial DNA (mtDNA).  The company combines decades of expertise in mitochondrial function, drug discovery and development, and use of the virtual company model to become the leader in correcting oxidative damage to mtDNA.

Luciole is applying cutting edge science to enhance the functionality of OGG1 (8-oxoguanine DNA glycosylase), the key enzyme in the initiation of base excision repair (BER) of mtDNA.

The Management Team
Dennis_edited.jpg
Dennis Goldberg, PhD
President and CEO, Director, Co-founder
Rumsey_edited.jpg
Bill Rumsey, PhD
Vice President and CSO, Director, Co-founder
Eric_edited.jpg
Eric Morrel, PhD
Vice President and COO, Director, Co-founder
Donald-114[2305843009229551444] (2)_edited.jpg

Donald Dye

Director

Scientific Advisors
Lloyd picture.png
McCullough.png

Stephen Lloyd, PhD

Co-founder

Professor, Molecular and Medical Genetics, School of Medicine, Oregon Health and Science University

Amanda K. McCullough, PhD

Co-founder

Professor, Molecular and Medical Genetics, School of Medicine,

Oregon Health and Science University

Serge Przedborski, MD, PhD

Page and William Black Professor of Neurology

Chief, Division of Movement Disorders

Columbia University Irving Medical Center

 
Kaufman.jpg

Brett Kaufman, PhD

Associate Professor of Medicine

University of Pittsburgh

Ralph Rivero_Formal (2).jpg
Ralph A. Rivero, PhD
Medicinal Chemist
steer.jpg
Purnell.png

Clifford Steer, MD

Professor of Medicine, University of Minnesota

Jonathan Q. Purnell, MD
Professor of Medicine, Division of Cardiovascular Medicine
Oregon Health & Science University

firefly%25252520%25252520design%2525255B